Discover top biotech companies for 2026, featuring emerging stars and leaders set for major clinical and regulatory ...

A combination of a relatively low-risk approval process, growing sales, and a very attractive valuation based on management's peak sales estimations makes this biotech stock attractive.

The biotech sector has been a disaster for investors over the past five years going by a 14% decline compared to an 86% gain ...

In this article, we will take a look at 9 Oversold Biotech Stocks to Invest In. Biotech companies are making a solid comeback following an extended slump as investors shift their focus back to value ...

Promoting innovation through capital-market innovation and regulatory modernisation, like China did, is the way to go ...

The George Soros protege has generated legendary returns for decades, so it's hard not to take stock in where Druckenmiller is investing. Three biotech stocks in his private investment firm, Duquesne ...

Think spotting Ten Baggers is luck? Think again. This tool identified every ASX Ten Bagger in 2025 – and it’s gearing up for ...

Saluda Medical will list on the ASX this week after raising more than $230 million to drive sales growth for its pain relief ...

BeOne Medicines is up 75% in 2025 but off recent highs. China’s new private insurance drug list could unlock major growth for ONC in 2026.